The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
NCT Number: NCT03782844
Obstructive sleep apnea (OSA) is a common and frequently-occurring disease. The incidence of OSA is more than 4% in general population, and as high as 20% - 40% in the elderly. At present, CPAP machines commonly used for OSA treatment includes traditional pressure fixed single-level CPAP machine and automatic pressure regulation CPAP machine. Studies have shown that the CPAP treatment pressure of OSA patients is normally below 11 cmH2O. Since the condition of OSA patients and the required CPAP treatment pressure may change over time, a CPAP machine with automatic pressure regulation function may theoretically better meet the needs of treatment. However, a recent large-scale clinical study with an average follow-up of four years showed that there was little need to change CPAP treatment pressure after titration. Although different types of CPAP have different functions, the basic principle is to keep the upper airway open and unobstructed to eliminate sleep apnea and hypopnea by continuously applying positive pressure to the upper respiratory tract through an air pump. A complex CPAP machine with functions such as pressure regulation, boost delay, end-expiratory pressure release will cost more than a single-function CPAP machine. Some patients from poor areas, even with severe OSA, may give up treatment when they can not afford CPAP machines that have not yet been included in national health insurance in China. In view of the current economic level in China, it is urgent to find an inexpensive and effective CPAP machine for the treatment of OSA and related complications. Recently, Guangzhou Yinghui Medical Technology Co., Ltd.and State Key Laboratory of Respiratory Disease have developed a new simple CPAP machine. The CPAP treatment pressure is fixed at the factory to 6 cm H2O (SKL), 8 cm H2O (SKM) and 10 cm H2O (SKH). Compared to traditional CPAP machine, only a power switch button is attached on the body, and the additional adjustment devices including display screen are removed, which not only reduces the cost of the CPAP machine, but also facilitates the operation of patients.
Looking for future studies?
Notify Me16 year and older
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, China
Study Design: A randomized, cross-over and double blind study . Objective: To investigate the efficacy of simple device of continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea (OSA). Methods: A randomized, cross-over and double blind study would be performed on 100 OSA patients using both simple CPAP and traditional CPAP during overnight polysomnography. Pressure for CPAP treatment would be manual titrated. The sleep apnea hypopnea index (AHI), arousal index (ArI), Oxygen desaturation Index (ODI), sleep structure and the preference of CPAP model were to be observed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients used simple CPAP and conventional fixed CPAP during overnight polysomnography.
Patients used simple CPAP and Auto CPAP during overnight polysomnography.
Time frame: One full night
Total number of apneas and hypopneas×60/total sleep time
Time frame: One full night
Total number of arousals×60/total sleep time
Time frame: One full night
Total number of oxygen desaturations≥3%×60/total sleep time
Time frame: One full night
Sleep stage distribution(N1, N2, N3, NREM)
Time frame: Onefull night
Using questionnaire to assess adverse effects including dyspnea, noise, bloating, et al
State Key Laboratory of Respiratory Disease
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03445962
Abnormalities, Multiple, Apnea
Échirolles, France
View Trial DetailsNCT00623246
Apnea, Continuous Positive Airway Pressure
Denver, Colorado, United States
View Trial DetailsNCT03221205
Apnea, Body Weight
Mexico City, Delegacion Tlalpan, Mexico
View Trial DetailsNCT06573372
Apnea, Dyssomnias
Beijing, Beijing Municipality, China
View Trial Details